{"hands_on_practices": [{"introduction": "The power of ChIP-seq lies in its ability to map protein-DNA interactions with high precision across the entire genome. However, the ultimate spatial resolution of this map is not determined by the sequencer, but by a crucial physical step: the fragmentation of chromatin. This exercise [@problem_id:2308881] challenges you to think about how the physical size of your DNA fragments directly impacts your ability to pinpoint a binding site, a fundamental concept in designing and evaluating any ChIP-seq experiment.", "problem": "A molecular biology student is performing a Chromatin Immunoprecipitation Sequencing (ChIP-seq) experiment to map the binding sites of a specific transcription factor, let's call it TFX, across the yeast genome. The goal of ChIP-seq is to precisely identify the DNA sequences to which a protein of interest is bound *in vivo*. A critical step in the procedure is the mechanical shearing (sonication) of chromatin to break it into smaller fragments. Ideally, this process yields a population of DNA fragments predominantly in the 200-600 base pair (bp) range.\n\nAfter performing the experiment and sequencing the resulting DNA, the student analyzes the quality control data. They discover that the sonication step was insufficient, and a vast majority of the DNA fragments that were sequenced are larger than 1500 bp. All other steps of the protocol, including protein-DNA cross-linking, immunoprecipitation with a highly specific anti-TFX antibody, and DNA sequencing, were executed correctly.\n\nWhich of the following statements best describes the most direct and significant consequence of having such large DNA fragments on the final interpretation of the ChIP-seq data?\n\nA. The experiment will yield no usable data because the anti-TFX antibody cannot bind to the transcription factor when it is attached to such a large piece of DNA.\n\nB. The experiment will identify TFX binding sites with very low spatial resolution, making it difficult to determine the precise location of TFX binding motifs.\n\nC. The experiment will primarily identify binding sites within heterochromatin regions, as larger fragments are more likely to originate from tightly packed DNA.\n\nD. The total number of sequencing reads will be far too low to achieve statistical significance, as next-generation sequencing platforms systematically reject fragments larger than 1000 bp.\n\nE. The data will show a strong bias towards the 5' ends of genes, as large DNA fragments are more easily amplified during the library preparation stage.", "solution": "ChIP-seq relies on cross-linking protein to DNA, fragmenting chromatin by sonication, immunoprecipitating the protein-DNA complexes with a specific antibody, reversing cross-links, and sequencing the associated DNA. The spatial resolution with which binding sites can be localized depends primarily on the fragment length distribution generated by sonication, because the immunoprecipitated DNA fragments are centered around, but extend beyond, the true binding site by approximately half the fragment length on either side.\n\nIf chromatin is insufficiently sheared and fragments are predominantly larger than 1500 bp, then each immunoprecipitated fragment contains the true TFX binding site plus large flanking regions. When mapped back to the genome, the resulting enrichment peaks become broad and diffuse, and the uncertainty interval for the binding site position expands proportionally to fragment size. This directly degrades the ability to pinpoint the precise binding motif or assign binding to specific promoter elements when multiple candidate sites lie within a large fragment.\n\nEvaluation of options:\n- A is incorrect because the antibody targets the protein (TFX), not the DNA fragment size; cross-linking preserves protein-DNA association, and fragment length does not prevent antibody binding.\n- B is correct because excessively large fragments directly reduce spatial resolution, broadening peaks and obscuring the precise location of the TFX binding motif.\n- C is incorrect because under-sonication does not inherently bias the pull-down toward heterochromatin in a TFX-targeted IP; the dominant effect is reduced resolution rather than chromatin-state-specific enrichment.\n- D is incorrect because next-generation sequencing platforms sequence fixed read lengths from library inserts; they do not systematically reject long inserts at the sequencing stage, though library construction may be less efficient. The primary interpretive consequence remains poor resolution, not an unavoidable collapse in read count.\n- E is incorrect because a 5' end bias is not a typical outcome of large genomic DNA fragments in ChIP-seq; PCR generally favors shorter fragments, and there is no intrinsic shift toward 5' gene ends caused by long inserts in this context.\n\nTherefore, the most direct and significant consequence is loss of spatial resolution in identifying TFX binding sites.", "answer": "$$\\boxed{B}$$", "id": "2308881"}, {"introduction": "A successful ChIP-seq experiment is a battle against background noise. To confidently claim that a peak in your data represents a true protein binding event, you must first account for various artifacts. This practice [@problem_id:2308930] explores the crucial roles of the two main sentinels in this process: the 'input' DNA control and the non-specific 'IgG' immunoprecipitation. Understanding their distinct functions is key to designing experiments that can reliably distinguish signal from noise.", "problem": "A molecular biologist is conducting a Chromatin Immunoprecipitation Sequencing (ChIP-seq) experiment to identify the genomic binding sites of a novel transcription factor, \"Factor Y\", in a human cell line. To distinguish true binding sites from experimental artifacts, the researcher includes two standard controls alongside the specific anti-Factor Y antibody sample:\n1.  **Input DNA Control:** A sample of the sonicated chromatin prepared from the initial cell lysate, which does not undergo the immunoprecipitation (IP) step.\n2.  **IgG Mock IP Control:** A sample that undergoes the complete IP procedure, but using a non-specific Immunoglobulin G (IgG) antibody that is of the same isotype as the anti-Factor Y antibody but is not expected to bind any specific protein in the lysate.\n\nAll three samples (Factor Y ChIP, Input, and IgG) are then subjected to DNA purification, library preparation, and high-throughput sequencing. Which of the following statements accurately describe the roles of these controls in the analysis of the ChIP-seq data? Select all that apply.\n\nA. The IgG Mock IP control is primarily used to account for biases introduced during the sonication of chromatin, as it models the fragmentation of both open and closed chromatin regions.\n\nB. The Input DNA control serves to identify genomic loci that are prone to non-specific binding to the antibody or the magnetic beads used in the immunoprecipitation step.\n\nC. The Input DNA control provides a baseline for local copy number variations and biases in sequencing read mappability across the genome.\n\nD. A genomic region showing significant signal enrichment in the Factor Y ChIP sample relative to the IgG Mock IP control, but not relative to the Input DNA control, likely represents an artifact of open chromatin rather than a true binding site.\n\nE. \"Hyper-ChIPable\" regions, which are loci that artifactually appear enriched in many unrelated ChIP experiments, are best identified and filtered out by comparing the specific ChIP signal to the IgG Mock IP control signal.", "solution": "We evaluate each statement against standard roles of ChIP-seq controls.\n\nFor option A: The IgG mock IP control undergoes the full IP workflow and is primarily used to measure nonspecific enrichment arising from the antibody-bead complex and generally sticky loci captured during IP. Sonication-induced fragmentation and genome-wide background (including open versus closed chromatin accessibility effects before IP) are controlled by the Input DNA, not primarily by IgG. Therefore, A is incorrect.\n\nFor option B: The Input DNA control bypasses the IP step entirely; it does not experience antibody-bead interactions. Thus, it cannot identify loci that bind nonspecifically to antibodies or beads during IP. Those nonspecific interactions are captured by the IgG mock IP. Therefore, B is incorrect.\n\nFor option C: The Input DNA control represents the genome after fragmentation and before IP, providing a baseline for background coverage shaped by local copy number, GC content, PCR/sequencing biases, and mappability differences. Comparing the ChIP signal to Input adjusts for these genome-wide biases. Therefore, C is correct.\n\nFor option D: If a region is enriched in Factor Y ChIP relative to IgG but not relative to Input, then the Input already shows high signal there. This pattern is characteristic of accessible or otherwise bias-prone regions (e.g., open chromatin, high copy number, mappability or GC-related biases), implying that the apparent enrichment over IgG is not specific to Factor Y binding. Therefore, D is correct.\n\nFor option E: Hyper-ChIPable regions, which artifactually enrich across many unrelated ChIP experiments, often appear in IgG mock IP because they reflect nonspecific capture during the IP process. Comparing the specific ChIP to IgG is the most direct way to detect and filter these loci. Therefore, E is correct.\n\nCombining the above, the correct choices are C, D, and E.", "answer": "$$\\boxed{CDE}$$", "id": "2308930"}, {"introduction": "Beyond identifying where a protein binds, ChIP-seq is a powerful quantitative tool for measuring *how much* protein is there, enabling comparisons between different conditions or cell types. However, raw read counts can be misleading, especially in complex biological systems like cancer where the amount of underlying DNA can vary. This final practice [@problem_id:2308894] demonstrates how to apply a critical data normalization technique, using the input control to correct for genomic copy number changes and reveal the true biological story.", "problem": "A cancer biologist is investigating the epigenetic landscape of a primary liver tumor compared to matched normal liver tissue from the same patient. They are specifically interested in the H3K4me3 histone modification, a marker for active gene promoters. They perform Chromatin Immunoprecipitation Sequencing (ChIP-seq), a technique that quantifies the amount of DNA associated with a specific protein or histone modification across the genome.\n\nIn a ChIP-seq experiment, DNA fragments bound by the target protein (here, histone H3 with the K4me3 modification) are isolated using a specific antibody and then sequenced. The number of sequencing reads mapping to a genomic region is proportional to the amount of the target protein bound in that region. To control for biases, including local DNA copy number variations common in cancer, a parallel \"input\" sample is prepared. The input sample consists of total genomic DNA that has been processed similarly but without the antibody-based immunoprecipitation step. Thus, read counts from the input sample reflect the baseline amount of DNA present at each genomic locus.\n\nThe biologist focuses on the promoter region of a gene called *FGF19*. Analysis of the sequencing data yields the following read counts mapped to the *FGF19* promoter:\n\n*   **Normal Tissue:**\n    *   ChIP-seq reads (H3K4me3): 250\n    *   Input reads: 125\n\n*   **Tumor Tissue:**\n    *   ChIP-seq reads (H3K4me3): 1200\n    *   Input reads: 300\n\nBased on this data, calculate the fold-change of the specific H3K4me3 enrichment at the *FGF19* promoter in the tumor tissue relative to the normal tissue. This value should represent the change in histone modification occupancy after accounting for any differences in the underlying DNA copy number. Report your answer as a numerical value rounded to three significant figures.", "solution": "We want the fold-change in specific H3K4me3 enrichment at the FGF19 promoter in tumor relative to normal while accounting for local DNA copy number. To do this, we first compute the input-normalized enrichment in each sample as the ratio of ChIP-seq reads to input reads, and then take the ratio of tumor to normal.\n\nDefine the specific enrichment for each sample as:\n$$\nE=\\frac{\\text{ChIP reads}}{\\text{Input reads}}.\n$$\n\nFor the normal tissue:\n$$\nE_{\\text{normal}}=\\frac{250}{125}=2.\n$$\n\nFor the tumor tissue:\n$$\nE_{\\text{tumor}}=\\frac{1200}{300}=4.\n$$\n\nThe fold-change of tumor relative to normal is:\n$$\n\\text{Fold-change}=\\frac{E_{\\text{tumor}}}{E_{\\text{normal}}}=\\frac{\\frac{1200}{300}}{\\frac{250}{125}}=\\frac{4}{2}=2.\n$$\n\nRounding to three significant figures gives:\n$$\n2.00.\n$$", "answer": "$$\\boxed{2.00}$$", "id": "2308894"}]}